FMR LLC 13D and 13G filings for Zenas BioPharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-08 11:46 am Purchase | 2025-08-29 | 13G | Zenas BioPharma, Inc. ZBIO | FMR LLC | 4,644,279 11.000% | 1,320,745 (+39.74%) | Filing |
| 2025-08-06 12:19 pm Purchase | 2025-06-30 | 13G | Zenas BioPharma, Inc. ZBIO | FMR LLC | 3,323,534 7.900% | 471,163 (+16.52%) | Filing |
| 2025-05-12 10:20 am Purchase | 2025-03-31 | 13G | Zenas BioPharma, Inc. ZBIO | FMR LLC | 2,852,371 6.800% | 852,371 (+42.62%) | Filing |
| 2024-11-12 10:40 am Purchase | 2024-11-08 | 13G | Zenas BioPharma, Inc. ZBIO | FMR LLC | 2,000,000 5.026% | 2,000,000 (New Position) | Filing |